Multiple pathways of TWEAK-induced cell death

Journal of Immunology

Volumn 168, Issue 2, 2002, Pages 734-743

  Nakayama, M ^a   Ishidoh, K ^a   Kayagaki, N ^a   Kojima, Y ^a   Yamaguchi, N ^a   Nakano, H ^a   Kominami, E ^a   Okumura, K ^a   Yagita, H ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CYCLOHEXIMIDE; GAMMA INTERFERON; HLA DR3 ANTIGEN; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TWEAK; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STIMULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; SENSITIZATION; TUMOR CELL LINE;

EID: 0037080352     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.2.734     Document Type: Article

References (48)

1. Apoptosis by death factor
2. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
3. Signaling by the TNF receptor superfamily and T cell homeostasis
4. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
5. TWEAK induces angiogenesis and proliferation of endothelial cells
6. Identification of a ligand for the death-domain-containing receptor Apo3
7. Involvement of TWEAK in intefferon-γ-stimulated monocyte cytotoxicity
8. Death receptors: Signaling and modulation
9. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
10. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
11. Cathepsin B contributes to TNF-αmediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c
12. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor
13. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis
14. Noncaspase proteases in apoptosis
15. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways
16. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor
17. Resistance to the cytotoxic effects of tumor necrosis factor a can be overcome by inhibition of a FADD/caspase-dependent signaling pathway
18. Necrotic death pathway in Fas receptor signaling
19. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
20. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95)
21. LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing
22. TWEAK can induce cell death via endogenous TNF and TNF receptor 1
23. Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)
24. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
25. Prevention of apoptosis by Bcl-2: Release of cytochrome from mitochondria blocked
26. Effect of metabolic alterations on the density and the contents of cathepsins B, H and L of lysosomes in rat macrophages
27. Type I intefferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
28. Metalloproteinase-mediated release of human Fas ligand
29. + T cell-mediated cytotoxicity
30. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro
31. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease
32. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b
33. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
34. Nitric oxide and cell death
35. Sphingosine: A mediator of acute renal tubular injury and subsequent cytoresistance
36. More than one way to die: Apoptosis, necrosis and reactive oxygen damage
37. Caspase-independent programmed cell death with necrotic morphology
38. CA074 methyl ester: A proinhibitor for intracellular cathepsin B
39. Analysis of where and which types of proteinases participate in lysosomal proteinase processing using bafilomycin A1 and Helicobacter pylori Vac A toxin
40. Human tumour cathepsin B: Comparison with normal liver cathepsin B
41. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
42. CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor supeffamily
43. IFN-γ- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: An application of allografting to cancer treatment
44. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression
45. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression
46. Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells
47. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation
48. DR3 regulates negative selection during thymocyte development